on november 8th, icap and its shareholder hybio (300199) collaborated with the japanese company fuji yakuhin on a gout medicine project.
zeng shaogui, chairman of hybio(front row, first from left), takayanagi masayuki, president of fuji pharmaceutical(first right, first from right) and song siyun, board member, vice general manager of icap (back row, third from left,) signed the contract in shenzhen.
no.8 huaxia road, zhujiang new town, guangzhou, china
买球软件推荐 copyright 2021 infinite capital holding company all right reserved. 粤icp备18101238号 粤公网安备 44010602006158号